Amsterdam 2013 Programme Satellite Meetings Registration Exhibition Virtual Exhibition Hotels Visa Letter Invitation
Search Abstracts by author or title
(results will display both Free Papers & Poster)

Intracameral ranibizumab and subsequent mitomycin C augmented trabeculectomy in neovascular glaucoma

Poster Details

First Author: A.Khafagy EGYPT

Co Author(s):    T. Belal              

Abstract Details



Purpose:

The purpose of this study is to evaluate the efficacy of intracameral Ranibizumab injection with subsequent Mitomycin C augmented trabeculectomy in managing neovascular glaucoma.

Setting:

Ophthalmology department, Kasr El-Aini Hospital and Petrol Medical Center, Cairo, Egypt

Methods:

This is a prospective, interventional study that included 15 eyes of 15 patients with neovascular. In all eyes, intracameral injection of Ranibizumab (0.5 mg) was done and subsequent Mitomycin C augmented trabeculectomy was performed within 4 weeks from the injection. All patients were followed for 6 months.

Results:

13 eyes (86.7%) had complete regression of iris neovascularization after one intracameral Ranibizumab injection and 2 eyes (13.3%) after a second injection. 8 eyes (53.3%) achieved complete success (if the intraocular pressure was between 10-21 mmHg) without topical antiglaucoma medications, 6 eyes (40%) had qualified success (if the intraocular pressure was within the same range) but with topical antiglaucoma medications and failure occurred in one eye (6.7%) (if the intraocular pressure was above 21mmHg) despite the use of topical antiglaucoma medications.

Conclusions:

Intracameral Ranibizumab injection with subsequent Mitomycin C augmented trabeculectomy is an effective surgical technique in controlling intraocular pressure in eyes with neovascular glaucoma.

Financial Disclosure:

NONE

Back to previous